retatrutide low libido Tirzepatide vs. Retatrutide: Key Differences Explained Retatrutide vs Survodutide: 24% vs

Description

ELIXA trial included patients with recent cardiovascular event (patients with acute coronary syndrome 180 days before randomization), and although there was no benefit in MACE reduction in lixisenatide treated patients compared to placebo, results revealed cardiovascular safety of lixisenatide in this specific high risk population (38, 40)

In contrast, short-acting GLP-1RAs, such as lixisenatide, require more frequent dosing due to shorter half-lives, resulting in intermittent receptor stimulation that may reduce the risk of diarrhea

For AUD or smoking indications, expect prior-authorization denials until FDA labeling changes

Beyond changes in calorie intake, only eight studies, to date, have evaluated changes in macronutrient intake in GLP-1 RA users

Conversely, depression can undermine self-care behaviors that are necessary for effective diabetes management, such as regular medication adherence, appropriate dietary choices, and consistent physical activity [30, 33]